Khoja Hamid, Chief Scientific Officer of FibroBiologics, Inc. ($FBLG), made two open market purchases of company shares in the last 365 days, totaling $28,200. His most recent buy occurred on March 4, 2026. These purchases rank 3,497th among nearly 5,000 insiders in our database, where the average buy amounts to $1.46 million across 3.29 transactions. Hamid reported no open market sales during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 4, 2026 | FibroBiologics, Inc. | $FBLG | Khoja Hamid | Chief Scientific Officer | P | Common Stock | 30000 | $0.38 | 61,250.0000 | 51,456,077 | 96.00% | 0.06% |
| May 27, 2025 | FibroBiologics, Inc. | $FBLG | Khoja Hamid | Chief Scientific Officer | P | Common Stock | 20000 | $0.84 | 31,250.0000 | 37,735,300 | 177.78% | 0.05% |
| March 26, 2025 | FibroBiologics, Inc. | $FBLG | Khoja Hamid | CHIEF SCIENTIFIC OFFICER | A | Stock Option (Right to Buy) | 189000 | $0.00 | 189,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 27, 2024 | FibroBiologics, Inc. | $FBLG | Khoja Hamid | CHIEF SCIENTIFIC OFFICER | A | Stock Option (Right to Buy) | 176200 | $0.00 | 176,200.0000 | 0 | 9999.99% | 0.00% |
| Aug. 12, 2024 | FibroBiologics, Inc. | $FBLG | Khoja Hamid | Chief Scientific Officer | P | Common Stock | 10000 | $1.90 | 11,250.0000 | 0 | 800.00% | 0.00% |